Dr Graff on the Relation Between ctDNA Positivity and Disease Recurrence in HR+/HER2– Breast Cancer : vimarsana.com

Stephanie L. Graff, MD, discusses findings from a pilot study exploring the association between disease recurrence and circulating tumor DNA positivity in patients with hormone receptor–positive, HER2-negative, node-positive, high-risk, early breast cancer who have received adjuvant treatment of abemaciclib and endocrine therapy.

Related Keywords

San Antonio , Texas , United States , Stephaniel Graff , , Breast Cancer Translational Research Disease Group , Warren Alpert Medical School , Lifespan Cancer Institute , Brown University Legorreta Cancer Center , Brown University , Legorreta Cancer Center , Antonio Breast Cancer Symposium , Onclive Tv , Breast Cancer , Endocrine Therapy Interruption , Hr Positive Breast Cancer , Sabcs , Ctdna , Her2 Negative , Abemaciclib , Monarche ,